FAQ from Ibex
What is Ibex?
Revolutionizing Cancer Diagnosis with Intelligent Precision
How to use Ibex?
Our intuitive, browser-based platform requires no specialized hardware—simply upload digitized slides or connect via PACS/LIS; AI analysis begins instantly with clinician-in-the-loop validation.
How accurate are Ibex's diagnostic solutions?
Ibex's algorithms are validated across multi-center studies and demonstrate sensitivity and specificity exceeding 95% for key cancer subtypes—including prostate, breast, and colorectal cancers—with regulatory clearance in the US, EU, and Israel.
Who uses Ibex's AI platform?
Leading academic medical centers, community hospitals, reference labs, and global diagnostics partners rely on Ibex to augment pathology expertise, standardize reporting, and accelerate precision oncology pathways.
What are the benefits of using Ibex?
Reduced diagnostic turnaround time, decreased inter-observer variability, actionable biomarker insights, seamless EHR integration, and measurable improvements in case throughput—without compromising clinical autonomy.